Iriyama, Noriyoshi http://orcid.org/0000-0001-9176-1988
Sugimoto, Kei-Ji
Sato, Eriko
Takaku, Tomoiku
Tokuhira, Michihide
Nakazato, Tomonori
Ishikawa, Maho
Fujita, Hiroyuki
Fujioka, Isao
Kimura, Yuta
Asou, Norio
Kizaki, Masahiro
Komatsu, Norio
Hatta, Yoshihiro
Kawaguchi, Tatsuya
Article History
Received: 13 August 2018
Accepted: 5 September 2018
First Online: 7 September 2018
Compliance with ethical standards
:
: NI received honoraria and speaker fees from Bristol-Myers Squibb, Novartis Pharma K.K., Otsuka Pharmaceutical, and Pfizer Inc. MT received honoraria and speaker fees from Pfizer Inc. and Bristol-Myers Squibb. MK received honoraria and speaker fees from Bristol-Myers Squibb and Novartis Pharma K.K. TT, and YH received honoraria from Bristol-Myers Squibb and Novartis Pharma K.K. TK received honoraria and speaker fees from Bristol-Myers Squibb, Novartis Pharma K.K., and Pfizer Inc. The remaining authors declare no competing financial interests. All authors have no non-financial conflicts of interest to declare.
: All procedures performed in studies were in accordance with the ethical standards of each institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Written informed consent was not required due to retrospective fashion of this study.